Sanofi Drug Beats AbbVie's Blockbuster Humira in Human Trial

Sanofi Drug Beats AbbVie's Blockbuster Humira in Human Trial

Sanofi and Regeneron Pharmaceuticals Inc. said an experimental rheumatoid arthritis therapy helped patients more than AbbVie Inc.'s Humira in a late-stage trial. The treatment, sarilumab, improved signs and symptoms of rheumatoid arthritis more than …

(Visited 1 times, 1 visits today)
2
Like
Save

Comments

Comments are disabled for this post.